↓ Skip to main content

Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection

Overview of attention for article published in Cochrane database of systematic reviews, April 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 tweeters
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection
Published in
Cochrane database of systematic reviews, April 2013
DOI 10.1002/14651858.cd009004.pub2
Pubmed ID
Authors

Yun Xia, Hui Luo, Jian Ping Liu, Christian Gluud

Abstract

Phyllanthus species for patients with chronic hepatitis B virus (HBV) infection have been assessed in clinical trials, but no consensus regarding their usefulness exists. When compared with placebo or no intervention, we were unable to identify convincing evidence that phyllanthus species are beneficial in patients with chronic hepatitis B. Some randomised clinical trials have compared phyllanthus species versus antiviral drugs.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Unknown 74 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 18%
Student > Master 12 16%
Researcher 10 13%
Student > Postgraduate 8 11%
Student > Ph. D. Student 8 11%
Other 17 22%
Unknown 7 9%
Readers by discipline Count As %
Medicine and Dentistry 33 43%
Psychology 8 11%
Nursing and Health Professions 8 11%
Social Sciences 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 10 13%
Unknown 11 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2017.
All research outputs
#2,922,846
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#5,054
of 8,923 outputs
Outputs of similar age
#31,876
of 146,012 outputs
Outputs of similar age from Cochrane database of systematic reviews
#56
of 116 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 146,012 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.